Aaron Morawski

537 total citations
6 papers, 43 citations indexed

About

Aaron Morawski is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aaron Morawski has authored 6 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aaron Morawski's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Neurological diseases and metabolism (1 paper). Aaron Morawski is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Neurological diseases and metabolism (1 paper). Aaron Morawski collaborates with scholars based in United States and Poland. Aaron Morawski's co-authors include Timothy Gilpatrick, Chryssa Kanellopoulou, Patrick Burr, Gokhul Kilaru, Cuong Nguyen, Stefan A. Muljo, Michael J. Lenardo, Christina M. Carlson, Omid Hamid and Jahangheer Shaik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stem Cell Reports and BMC Veterinary Research.

In The Last Decade

Aaron Morawski

5 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aaron Morawski United States	3	34	19	9	9	3	6	43
Xueyun Bi China	3	29 0.9×	24 1.3×	10 1.1×	6 0.7×	2 0.7×	6	51
Monica Lewis United States	4	47 1.4×	21 1.1×	14 1.6×	13 1.4×	3 1.0×	6	78
Nora Diéguez-Martínez Spain	3	51 1.5×	13 0.7×	9 1.0×	11 1.2×	3 1.0×	3	64
Mario Quintero-Aguilo Puerto Rico	2	31 0.9×	26 1.4×	10 1.1×	10 1.1×	3 1.0×	2	54
Maya Ridinger-Saison France	3	42 1.2×	15 0.8×	5 0.6×	8 0.9×	1 0.3×	3	55
Sarah E. Glass United States	3	27 0.8×	15 0.8×	11 1.2×	6 0.7×	4 1.3×	4	39
Dina Ayupova United States	2	41 1.2×	18 0.9×	3 0.3×	8 0.9×	3 1.0×	4	54
Angela Schwarz‐Cruz y Celis Mexico	3	29 0.9×	21 1.1×	25 2.8×	6 0.7×	2 0.7×	3	51
Deviana Burhan United States	2	18 0.5×	9 0.5×	10 1.1×	9 1.0×	2 0.7×	2	41
Nataly Naser Al Deen Lebanon	6	38 1.1×	26 1.4×	12 1.3×	6 0.7×	2 0.7×	8	84

Countries citing papers authored by Aaron Morawski

Since Specialization

Citations

This map shows the geographic impact of Aaron Morawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Morawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Morawski more than expected).

Fields of papers citing papers by Aaron Morawski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Morawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Morawski. The network helps show where Aaron Morawski may publish in the future.

Co-authorship network of co-authors of Aaron Morawski

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Morawski. A scholar is included among the top collaborators of Aaron Morawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Morawski. Aaron Morawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Myint, Han, Martin Gutierrez, Emese Zsíros, et al.. (2022). 748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors. Regular and Young Investigator Award Abstracts. A781–A781. 1 indexed citations

2.

Shum, Elaine, Jahangheer Shaik, Qinjie Zhou, et al.. (2021). 490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors. SHILAP Revista de lepidopterología. A520–A521. 10 indexed citations

3.

Tian, Linjie, Jahangheer Shaik, Qinjie Zhou, et al.. (2021). 487 NC410, a fusion protein of LAIR-2 (Leukocyte Associated Immunoglobulin-like Receptor) with human IgG1 Fc, is safe & tolerable with evidence of immune modulation in subjects with advanced solid tumors. SHILAP Revista de lepidopterología. A516–A517.

4.

Kanellopoulou, Chryssa, Timothy Gilpatrick, Gokhul Kilaru, et al.. (2015). Reprogramming of Polycomb-Mediated Gene Silencing in Embryonic Stem Cells by the miR-290 Family and the Methyltransferase Ash1l. Stem Cell Reports. 5(6). 971–978. 26 indexed citations

5.

Morawski, Aaron, et al.. (2013). In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies. BMC Veterinary Research. 9(1). 157–157. 5 indexed citations

6.

Zwołińska, Danuta, et al.. (1993). [Histocompatibility antigens (HLA) in children with lipoid nephrosis].. PubMed. 47(31-33). 671–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact